1. Commentary: what factors are important in diagnosing hepatic fibrosis? Authors' reply. Issue 5 (4th February 2014) Authors: Maieron, A.; Ferlitsch, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 5(2014) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durability of SVR in chronic hepatitis C patients treated with peginterferon‐α2a/ribavirin in combination with a direct‐acting anti‐viral. Issue 2 (26th May 2013) Authors: Rutter, K.; Hofer, H.; Beinhardt, S.; Dulic, M.; Gschwantler, M.; Maieron, A.; Laferl, H.; Stättermayer, A. F.; Scherzer, T.‐M.; Strassl, R.; Holzmann, H.; Steindl‐Munda, P.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 2(2013) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Letter: retreatment of patients with chronic hepatitis C who have failed interferon‐free combination therapy with direct acting anti‐virals. Issue 2 (1st December 2016) Authors: Kozbial, K.; Aberle, S. W.; Susser, S.; Al‐Zoairy, R.; Moser, S.; Stättermayer, A. F.; Maieron, A.; Gschwantler, M.; Stauber, R.; Graziadei, I.; Zoller, H.; Beinhardt, S.; Holzmann, H.; Munda‐Steindl, P.; Hofer, H.; Sarrazin, C.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 2(2017) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Polymorphisms of interferon‐λ4 and IL28B – effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Issue 1 (10th November 2013) Authors: Stättermayer, A. F.; Strassl, R.; Maieron, A.; Rutter, K.; Stauber, R.; Strasser, M.; Beinhardt, S.; Datz, C.; Scherzer, T.‐M.; Steindl‐Munda, P.; Gschwantler, M.; Trauner, M.; Hofer, H.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 1(2014) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Issue 3 (5th December 2013) Authors: Maieron, A.; Salzl, P.; Peck‐Radosavljevic, M.; Trauner, M.; Hametner, S.; Schöfl, R.; Ferenci, P.; Ferlitsch, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 3(2014) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗